Filippo Acconcia

Filippo Acconcia

Sep 24, 2017

Group 6 Copy 218
1
Please wait...

About This Project

70% of breast cancers are estrogen receptor α (ERα)-positive. ERα is the antenna that senses the ovarian hormone estrogen (E2) and drives tumour cell proliferation and spreading. 4OH-tamoxifen and faslodex are given to patients to prevent cancer growth and spreading but they possess serious side effects. Thus, additional drugs are needed to fight breast cancer. We will explore existing drugs for the possibility of ‘reuse’ as breast cancer drugs.

Blast off!

Browse Other Projects on Experiment

Related Projects

Can cockroaches help us cure tularemia?

Tularemia is a deadly disease caused by the bacterium Francisella tularensis (Ft). This bacterium is also a...

Does bias about medical diagnosis link to expectations of mental health problems for infants and their parents?

If doctors think infants will have lower skill (e.g., less able to look and to smile at parents), does that...

First, do no harm: Institutional Betrayal in healthcare

Sick or injured patients depend upon healthcare providers to heal what ails them. But what if the very act of...

Campaign Ended